Related Experiment Videos
Aspects on reducing gastrointestinal adverse effects associated with radiotherapy
R Henriksson1, P Bergström, L Franzén
1Department of Oncology, Umeå University Hospital, Sweden.
Acta Oncologica (Stockholm, Sweden)
|May 5, 1999
Summary
Cancer radiotherapy causes significant mucosal toxicity, leading to pain, diarrhea, and decreased quality of life. Managing these side effects is crucial for optimizing treatment and patient outcomes.
Area of Science:
- Oncology
- Gastroenterology
- Palliative Care
Background:
- Radiotherapy for head and neck, oesophagus, and pelvic cancers frequently causes severe mucosal toxicity.
- Common symptoms include pain, diarrhea, nausea, and vomiting, leading to malnutrition and reduced quality of life.
Purpose of the Study:
- To summarize current approaches for managing radiotherapy-induced mucosal toxicity.
- To highlight the importance of preventing symptom aggravation and promoting healing of mucosal changes.
Main Methods:
- Review of agents used to palliate symptoms of mucosal toxicity.
- Discussion of interventions including antimicrobials, analgesics, anti-inflammatory drugs, anti-diarrhoeal drugs, and mucosal protectors.
- Consideration of dietetic care in managing side effects.
Main Results:
- Various agents are used to manage radiotherapy-induced side effects.
- Combination therapies and supportive care are essential for improving patient quality of life.
Conclusions:
- Effective management of mucosal toxicity is vital for successful cancer treatment.
- Further research and evaluation of therapeutic agents are ongoing to improve patient care.